(WBNG Binghamton) Lourdes Hospital and a Binghamton eye care facility were shipped dozens of products from the medical company responsible for the meningitis outbreak that's killed 25 people, according to information released this week from the U.S. Drug Administration.
The USDA issued an alert Oct. 22 that highlighted 3,000 companies across the country that had received shipments of products from the New England Compounding Center on or after May 21.
On the list in the Greater Binghamton area are Lourdes Hospital and Binghamton Eye Associates.
According to the USDA, Lourdes hospital received 257 products from the compounding center -- most of them drugs -- between May 30 and Aug. 23.
Binghamton Eye Associates on Mitchell Avenue received seven items from the NECC between July 9 and Sept. 18.
Wendy Campbell, clinical supervisor with Binghamton Eye Associates, said the facility is following all recommendations from the USDA and have set aside the medications in question.
Campbell said the business is awaiting further instruction from the Center for Disease Control.
Officials from Lourdes Hospital had no comment Friday about the USDA's data.
There is one confirmed case of fungal meningitis in New York and another in Pennsylvania. As of Friday, neither have resulted in death.